Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism
Clinical trial NCT05823012 · COMPLETED
Trial details
- NCT number
- NCT05823012
- Sponsor
- Xeris Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2024-02-22
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.